Spencer Gordon and Jenna Ryan are the co-founders of Uqora. Thanks to their recent announcement, the company is now positioning themselves as a leader in the world of UTI supplements. In a world where it is often challenging to find the necessary support in this regard, this news is music to the ears of observers everywhere.
Gordon and Ryan are engaging in clinical trials that are designed to assist those who are in need. As someone who experienced eight urinary tract infections in 2014 alone, Ryan is uniquely equipped to provide insight on this topic. She knows how awful the cycle can be and is looking to help the rest of the world to avoid the same issues she experienced.
After being told by various medical professionals that there was very little that she could do (outside of the normal suggested cures), she knew that it was time to take action. Gordon, Jenna’s longtime partner, was also tired of watching her continue to suffer. When they disagreed with the medical prognosis that was offered to them, they took action.
These experiences inspired the couple to start the Uqora company. Thanks to their dedication to helping others, Uqora now offers a wide range of unique products that are geared towards assisting those who find themselves in similar predicaments. When women require support with their urinary health, they turn to Uqora. There are no antibiotics to be found, either.
The products are natural, free of medications and filled with beneficial ingredients that are backed by scientific research. These ingredients include Vitamin B6, Vitamin C, d-mannose, green tea extract and curcumin. Each of these ingredients is designed to assist those who are experiencing urinary tract infections in a variety of different ways.
They offer a natural cleansing effect that cannot be achieved elsewhere. If the supplements are taken in the proper manner, the tablets and powdered drinks significantly boost urinary health. Clinical trials to measure the effectiveness of the products are currently taking place. Female volunteers who have suffered from multiple UTI’s within the past six months have been separated into two groups.
The first group will receive a placebo while the second one receives Uqora supplements. Results are going to be published by January 2021. Urinary tract infections are the second most common affliction of this nature in the nation. Thanks to these clinical trials, Ryan and Gordon are looking to successfully spread the word about the importance of urinary health and allow those who experience UTI’s to avoid reliance on antibiotics.
Traditional medicine failed to relieve the pain that Ryan was receiving and now, thousands of different users are able to take a far more proactive approach. By offering a natural approach to addressing this all too common issue, Uqora plans to create a more sustainable method for treating these infections.
As a privately held company, Uqora is able to specifically formulate products that offer the unique support that women need. Their commitment to the expanding of research in this space is commendable and more preventive solutions will be created for this current public health issue.